Fireworks weren't the only things skyrocketing this week. Several health-care stocks dazzled and popped also.
One of this week's big winners gave a positively received update on a clinical trial. Another gained from a larger partner increasing its stake by a significant amount. And the third received a nice affirmation from an investment firm, sparking shares to move higher.
Which three health-care stocks soared stupendously this week? Find out by watching the slideshow below.
Keith Speights has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Will This Drug Kick-Start Regeneron Pharmaceuticals Shares?
An immuno-oncology drug that's in the works could generate significant revenue growth someday.
This Double Whammy Caused Regeneron Pharmaceuticals Inc. to Fall 10% in November
Shareholders aren't seeing too clearly after this double-dose of news concerning lead drug Eylea.
Here's Why Regeneron Pharmaceuticals Inc. Slipped 10% in October
Tiny start-up AnaptysBio helped spread fear that Dupixent's ongoing commercial launch might fizzle out.